Mangoceuticals subsidiary designates 1M shares of 6% Series B Convertible Preferred

MANGOCEUTICALS, INC.

Series B Preferred has $10 stated value, 6% cumulative dividend payable quarterly.
Conversion price fixed at $1.50 per common share, with 4.999% beneficial ownership cap.
Liquidation preference of $12.50 per share plus accrued dividends; company can redeem at $12.50 after 3 years.
No voting rights except protective provisions requiring majority approval for adverse changes.
Issued by wholly-owned subsidiary Mango & Peaches Corp.; no immediate proceeds or issuance disclosed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.